275 related articles for article (PubMed ID: 24189589)
1. Cardiolipin remodeling in diabetic heart.
He Q; Han X
Chem Phys Lipids; 2014 Apr; 179():75-81. PubMed ID: 24189589
[TBL] [Abstract][Full Text] [Related]
2. AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function.
Athéa Y; Viollet B; Mateo P; Rousseau D; Novotova M; Garnier A; Vaulont S; Wilding JR; Grynberg A; Veksler V; Hoerter J; Ventura-Clapier R
Diabetes; 2007 Mar; 56(3):786-94. PubMed ID: 17327449
[TBL] [Abstract][Full Text] [Related]
3. Cardiolipin metabolism and the role it plays in heart failure and mitochondrial supercomplex formation.
Mejia EM; Cole LK; Hatch GM
Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):98-106. PubMed ID: 24801725
[TBL] [Abstract][Full Text] [Related]
4. Cardiolipin remodeling in the heart.
Sparagna GC; Lesnefsky EJ
J Cardiovasc Pharmacol; 2009 Apr; 53(4):290-301. PubMed ID: 19276988
[TBL] [Abstract][Full Text] [Related]
5. Thyroxine regulation of monolysocardiolipin acyltransferase activity in rat heart.
Mutter T; Dolinsky VW; Ma BJ; Taylor WA; Hatch GM
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):403-6. PubMed ID: 10677359
[TBL] [Abstract][Full Text] [Related]
6. Differential reduction in cardiac and liver monolysocardiolipin acyltransferase-1 and reduction in cardiac and liver tetralinoleoyl-cardiolipin in the α-subunit of trifunctional protein heterozygous knockout mice.
Mejia EM; Ibdah JA; Sparagna GC; Hatch GM
Biochem J; 2015 Oct; 471(1):123-9. PubMed ID: 26251360
[TBL] [Abstract][Full Text] [Related]
7. Alterations in fatty acid metabolism and sirtuin signaling characterize early type-2 diabetic hearts of fructose-fed rats.
Lou PH; Lucchinetti E; Scott KY; Huang Y; Gandhi M; Hersberger M; Clanachan AS; Lemieux H; Zaugg M
Physiol Rep; 2017 Aug; 5(16):. PubMed ID: 28830979
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid lowers cardiac mitochondrial enzyme activity by replacing linoleic acid in the phospholipidome.
Sullivan EM; Pennington ER; Sparagna GC; Torres MJ; Neufer PD; Harris M; Washington J; Anderson EJ; Zeczycki TN; Brown DA; Shaikh SR
J Biol Chem; 2018 Jan; 293(2):466-483. PubMed ID: 29162722
[TBL] [Abstract][Full Text] [Related]
9. Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction.
Han X; Yang J; Cheng H; Yang K; Abendschein DR; Gross RW
Biochemistry; 2005 Dec; 44(50):16684-94. PubMed ID: 16342958
[TBL] [Abstract][Full Text] [Related]
10. Acylation of monolysocardiolipin in rat heart.
Ma BJ; Taylor WA; Dolinsky VW; Hatch GM
J Lipid Res; 1999 Oct; 40(10):1837-45. PubMed ID: 10508203
[TBL] [Abstract][Full Text] [Related]
11. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse.
Cao J; Liu Y; Lockwood J; Burn P; Shi Y
J Biol Chem; 2004 Jul; 279(30):31727-34. PubMed ID: 15152008
[TBL] [Abstract][Full Text] [Related]
12. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
Ikon N; Ryan RO
Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
[TBL] [Abstract][Full Text] [Related]
13. Barth syndrome, a human disorder of cardiolipin metabolism.
Schlame M; Ren M
FEBS Lett; 2006 Oct; 580(23):5450-5. PubMed ID: 16973164
[TBL] [Abstract][Full Text] [Related]
14. Enhanced modification of cardiolipin during ischemia in the aged heart.
Lesnefsky EJ; Minkler P; Hoppel CL
J Mol Cell Cardiol; 2009 Jun; 46(6):1008-15. PubMed ID: 19303420
[TBL] [Abstract][Full Text] [Related]
15. Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease.
Paradies G; Petrosillo G; Paradies V; Ruggiero FM
Cell Calcium; 2009 Jun; 45(6):643-50. PubMed ID: 19368971
[TBL] [Abstract][Full Text] [Related]
16. In yeast, cardiolipin unsaturation level plays a key role in mitochondrial function and inner membrane integrity.
Luévano-Martínez LA; Pinto IFD; Yoshinaga MY; Miyamoto S
Biochim Biophys Acta Bioenerg; 2022 Oct; 1863(7):148587. PubMed ID: 35780857
[TBL] [Abstract][Full Text] [Related]
17. Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy.
Cole LK; Mejia EM; Sparagna GC; Vandel M; Xiang B; Han X; Dedousis N; Kaufman BA; Dolinsky VW; Hatch GM
J Mol Cell Cardiol; 2020 Jul; 144():24-34. PubMed ID: 32418915
[TBL] [Abstract][Full Text] [Related]
18. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
Ye C; Shen Z; Greenberg ML
J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardiolipins from Drosophila strains with mutations in putative remodeling enzymes.
Schlame M; Blais S; Edelman-Novemsky I; Xu Y; Montecillo F; Phoon CK; Ren M; Neubert TA
Chem Phys Lipids; 2012 Jul; 165(5):512-9. PubMed ID: 22465155
[TBL] [Abstract][Full Text] [Related]
20. Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species.
Malhotra A; Xu Y; Ren M; Schlame M
Biochim Biophys Acta; 2009 Apr; 1791(4):314-20. PubMed ID: 19416660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
